title: [Resistance phenotypes circulating in nosocomial high risk departments].
abstract: OBJECTIVE
  Between November 2001-January 2002 we collected 406 samples from patients hospitalized in Intensive Care adults and new-borns Unit (ICU). The aim was to observe the colonization and infection status with bacteria that may have nosocomial potential and to establish circulating phenotypes in ICUs.
  
  
  METHODS
  The identification was performed by API (bioMerieux) method, and we have performed the antimicrobial susceptibility tests by both: API method and by Kirby-Bauer disc-diffusion test.
  
  
  RESULTS
  We isolated 295 strains with nosocomial potential: 34 MRSA strains, 23 MRCNS strains, 29 ESBL producing gram negative rods, etc.
  
  
  CONCLUSIONS
  We observed the presence of multiple drug resistant bacteria which play an important roll in both: massive colonization of patients and in the etiology of nosocomial infections. This leads us to the conclusion that antibiotic resistance pattern should be interpreted by the bacteriologist and a consistent policy concerning the use of antimicrobial drugs in hospital settings should be instituted.
authors.affiliation: Catedra de Microbiologie, UMF Victor Babeş Timişoara.
authors.forename: Monica
authors.initials: M
authors.lastname: Licker
authors.forename: Roxana
authors.initials: R
authors.lastname: Moldovan
authors.forename: Luminiţa
authors.initials: L
authors.lastname: Bădiţoiu
authors.forename: C O
authors.initials: CO
authors.lastname: Negru
authors.forename: Delia
authors.initials: D
authors.lastname: Berceanu-Văduva
authors.forename: Mihaela
authors.initials: M
authors.lastname: Crăciunescu
authors.forename: Delia
authors.initials: D
authors.lastname: Muntean
authors.forename: Elena
authors.initials: E
authors.lastname: Hogea
authors.forename: Dorina
authors.initials: D
authors.lastname: Branea
authors.forename: Liliana
authors.initials: L
authors.lastname: Dan
authors.forename: D
authors.initials: D
authors.lastname: Săndesc
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D003428:Cross Infection / Q000188:drug therapy / Q000382:microbiology*; D004352:Drug Resistance, Microbial; D004926:Escherichia coli / Q000187:drug effects; D006801:Humans; D007231:Infant, Newborn; D007362:Intensive Care Units; D007711:Klebsiella pneumoniae / Q000187:drug effects; D008826:Microbial Sensitivity Tests; D010641:Phenotype; D012189:Retrospective Studies; D013211:Staphylococcus aureus / Q000187:drug effects
chemical_list: D000900:Anti-Bacterial Agents